InvestSMART

Rhythm Biosciences Limited (ASX: RHY) - Announcements

- Current share price for RHY : $0.082

ASX company news and announcements for Rhythm Biosciences Limited (RHY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Rhythm Biosciences Limited (RHY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Rhythm Biosciences Limited (RHY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Rhythm Biosciences Limited (RHY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$29 Application for quotation of securities - RHY 7 Apr 2022 12:49PM $1.650 $0.082 fallen by 95.03%
$29 RHY Presentation at PAC Partners Healthcare Conference 6 Apr 2022 9:28AM $1.700 $0.082 fallen by 95.18%
$29 Rhythm Biosciences - Investor Presentation 5 Apr 2022 9:33AM $1.760 $0.082 fallen by 95.34%
$29 Study 7 Confirms ColoSTAT Meets Primary Endpoint 4 Apr 2022 9:32AM $1.470 $0.082 fallen by 94.42%
$29 Cleansing Notice 18 Mar 2022 2:18PM $1.290 $0.082 fallen by 93.64%
$29 Application for quotation of securities - RHY 18 Mar 2022 2:12PM $1.290 $0.082 fallen by 93.64%
$29 S&P DJI Announces March 2022 Quarterly Rebalance 4 Mar 2022 5:02PM $1.330 $0.082 fallen by 93.83%
$29 Rhythm Biosciences - Investor Webinar Presentation 2 Mar 2022 8:46AM $1.175 $0.082 fallen by 93.02%
$29 Appendix 4D and Half Yearly Report and Accounts 25 Feb 2022 9:34AM $1.120 $0.082 fallen by 92.68%
$29 Change of Company Address 25 Feb 2022 9:26AM $1.120 $0.082 fallen by 92.68%
$29 Appointment of New Company Secretary and General Counsel 25 Feb 2022 9:12AM $1.120 $0.082 fallen by 92.68%
$29 RHY Investor Webinar 24 Feb 2022 1:38PM $1.105 $0.082 fallen by 92.58%
$29 Rhythm Maintains Ongoing ISO13485 Certification 15 Feb 2022 9:08AM $1.260 $0.082 fallen by 93.49%
$29 Cleansing Notice 4 Feb 2022 4:22PM $1.365 $0.082 fallen by 93.99%
$29 Application for quotation of securities - RHY 4 Feb 2022 4:21PM $1.365 $0.082 fallen by 93.99%
$29 Cleansing Notice 1 Feb 2022 4:22PM $1.405 $0.082 fallen by 94.16%
$29 Application for quotation of securities - RHY 1 Feb 2022 4:20PM $1.405 $0.082 fallen by 94.16%
$29 Appendix 4C - quarterly 27 Jan 2022 9:09AM $1.245 $0.082 fallen by 93.41%
$29 Cleansing Notice 13 Jan 2022 4:45PM $1.525 $0.082 fallen by 94.62%
$29 Application for quotation of securities - RHY 13 Jan 2022 4:44PM $1.525 $0.082 fallen by 94.62%
$29 Cleansing Notice 12 Jan 2022 4:21PM $1.565 $0.082 fallen by 94.76%
$29 Application for quotation of securities - RHY 12 Jan 2022 4:18PM $1.565 $0.082 fallen by 94.76%
$29 Proposed issue of securities - RHY 6 Jan 2022 9:27AM $1.490 $0.082 fallen by 94.50%
$29 Placement of $6.5m to Global Institutional Funds Manager 6 Jan 2022 9:22AM $1.490 $0.082 fallen by 94.50%
$29 Rhythm Expands CE Mark Registration for ColoSTAT 6 Jan 2022 9:18AM $1.490 $0.082 fallen by 94.50%

401 - 425 of 645 results

Page 17 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.